They discovered that sCDP/DOX/miR-122 efficiently transported DOX and miR-122 into hepatoma cells and that miR-122 can subsequently be explicitly released from the nanosystem, increasing chemosensitivity and having synergistic consequences on cell proliferation inhibition [105]. Here, SCDP1 is linked to hepatocellular carcinoma.